Arcadia Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Arcadia Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $259.0 thousand for the year ending 2025.

  • Arcadia Biosciences, Inc. showed a decrease of -93.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $515.0 thousand | Q2 2014: $25.68 million | Q3 2014: $21.17 million | Q1 2015: $11.28 million | Q2 2015: $80.00 million | Q3 2015: $62.97 million | Q1 2016: $29.54 million | Q2 2016: $27.36 million | Q3 2016: $10.47 million | Q1 2017: $7.56 million | Q2 2017: $13.44 million | Q3 2017: $2.93 million | Q4 2017: $9.13 million | Q1 2018: $20.42 million | Q2 2018: $9.67 million | Q3 2018: $6.67 million | Q1 2019: $10.44 million | Q2 2019: $14.65 million | Q3 2019: $20.54 million | Q1 2020: $12.97 million | Q2 2020: $15.00 million | Q3 2020: $10.20 million | Q1 2021: $32.85 million | Q2 2021: $43.98 million | Q3 2021: $35.53 million | Q1 2022: $24.55 million | Q2 2022: $21.23 million | Q3 2022: $22.72 million | Q1 2023: $23.00 million | Q2 2023: $13.48 million | Q3 2023: $10.61 million | Q1 2024: $3.32 million | Q2 2024: $5.50 million | Q3 2024: $3.94 million | Q1 2025: $3.16 million | Q2 2025: $1.38 million | Q3 2025: $1.12 million.
  • Over the full 13 years of available data (2013 to 2025), Arcadia Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 90.9%.
  • Historical annual values: Fiscal year 2025: $259.0 thousand | Fiscal year 2024: $4.24 million | Fiscal year 2023: $6.52 million | Fiscal year 2022: $20.64 million | Fiscal year 2021: $28.69 million | Fiscal year 2020: $14.04 million | Fiscal year 2019: $8.42 million | Fiscal year 2018: $12.00 million | Fiscal year 2017: $9.13 million | Fiscal year 2016: $2.01 million | Fiscal year 2015: $23.97 million | Fiscal year 2014: $16.57 million | Fiscal year 2013: $2.84 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: